2. Academic Validation
  3. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37

Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37

  • Exp Cell Res. 2022 Oct 14;113377. doi: 10.1016/j.yexcr.2022.113377.
Yuzhen Ge 1,  Rui Zhao 2,  Bo Li 1,  Benli Xiao 1,  Lei Zhou 1,  Shi Zuo 3
Affiliations

Affiliations

  • 1 Clinical Medicine of Guizhou Medical University, Guiyang, Guizhou, China.
  • 2 Clinical Medicine of Guizhou Medical University, Guiyang, Guizhou, China; Department of Liver Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • 3 Clinical Medicine of Guizhou Medical University, Guiyang, Guizhou, China; Department of Liver Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: drzuoshi@gmc.edu.cn.
PMID: 36252649 DOI: 10.1016/j.yexcr.2022.113377
Abstract

Background: Hepatocellular carcinoma (HCC) is the most common primary liver Cancer in the world. In malignant liver Cancer, the increase of aerobic glycolysis indicates that the possibility of tumorigenesis is greatly enhanced. TRIM37 is a member of the TRIM family of proteins that possesses E3 ubiquitin Ligase activity and has been implicated in the occurrence and prognosis of many different tumors. However, the stability of P53 plays an important role in preventing tumorigenesis. The mechanism by which TRIM37 regulates the stability of P53 through ubiquitin in the progression of hepatocellular carcinoma is still unclear.

Materials and methods: Real-time quantitative polymerase chain reaction (qRT-PCR) and Western blotting were used to detect the expression of mRNA and protein in HCC cells. Lactic acid production, glucose uptake, and ATP levels were measured by BioVision kit. The following were used to assess the in vitro function of TRIM37 in HCC cells: cell counting kit-8 (CCK-8), colony formation assay, cell migration and invasion assay, and flow cytometry. We observed the effect of TRIM37 on the growth of transplanted tumors in nude mice. Co-Immunoprecipitation (Co-IP) revealed a binding relationship between TRIM37 and P53.

Results: The expression of TRIM37 in hepatocellular carcinoma (HCC) tissues was higher than that of normal tissues according to an analysis of The Cancer Genome Atlas (TCGA) database.Loss-of-function assays indicated that TRIM37 inhibited the proliferation, colony formation, migration, and invasion of liver Cancer cells. The mechanism is as follows: TRIM37 interacts with the P53 protein to induce E3 Ligase activity, ubiquitination, and degradation, further promoting the malignant characteristics of hepatocellular carcinoma, thus promoting the process of glycolysis. Genetic knockdown of P53 reversed the promoting function of TRIM37 on the growth and metastasis of hepatocellular carcinoma cells.

Conclusions: Our study showed that the TRIM37-P53 axis plays a role in the progression of liver Cancer, and thus is a potential target for the treatment of liver Cancer.

Keywords

Aerobic glycolysis; Hepatocellular carcinoma; P53; TRIM37; Ubiquitination.

Figures
Products